Pfizer Inc. on Thursday reported a 52 percent drop in third-quarter profit and withdrew its financial outlook through 2007 due to tumbling sales of its Celebrex arthritis drug and generic competition for other medicines.
The N.Y.-based drugmaker also said it expects 2005 earnings to fall as much as 9.4 percent, a steeper decline than its previous forecast.